Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study
NCT03857113 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-07-22
Summary
PSMA-radioguided surgery
Conditions
Interventions
- PROCEDURE
-
PSMA-radioguided surgery
PSMA-radioguided surgery
Sponsors & Collaborators
-
The Netherlands Cancer Institute
lead OTHER
Principal Investigators
-
Pim van Leeuwen, MD, PHD · NKI-AvL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-11
- Primary Completion
- 2022-03-01
- Completion
- 2022-03-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
NCT02334579 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT05435495 ·Status: RECRUITING
-
Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma
NCT03284151 ·Status: UNKNOWN
-
Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source
NCT06080113 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
NCT05867615 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
NCT07291557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients
NCT04832958 ·Status: COMPLETED ·Phase: PHASE2
-
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
NCT02077335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Salvage Prostatectomy After Radiotherapy
NCT00791115 ·Status: COMPLETED ·Phase: NA
-
Active Surveillance Magnetic Resonance Imaging Study
NCT01354171 ·Status: UNKNOWN ·Phase: PHASE3
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer
NCT02516995 ·Status: COMPLETED ·Phase: NA
-
Ga-68-PSMA-11 in High-risk Prostate Cancer
NCT03362359 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer
NCT00619515 ·Status: TERMINATED ·Phase: NA
-
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
NCT04053842 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT04857502 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer
NCT05161728 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT00002511 ·Status: COMPLETED ·Phase: PHASE3
-
Transperineal, MRI-guided, Prostate Biopsy
NCT02651948 ·Status: COMPLETED ·Phase: PHASE4
-
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions
NCT03213951 ·Status: COMPLETED
-
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485 ·Status: RECRUITING ·Phase: NA
-
177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease
NCT04297410 ·Status: UNKNOWN ·Phase: NA
-
MR-Lymphography and Lymph Node Staging in Prostate Cancer
NCT00185029 ·Status: UNKNOWN ·Phase: PHASE4
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA